Divis Laboratories Ltd | DIVI - Net Income



Divis Laboratories Ltd reported 5.45B in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Alaunos Therapeutics USD -742000 385K Dec/2024
Aurobindo Pharma INR 9.03B 576.6M Mar/2025
Avita Medical AUD -11589000 3.8M Dec/2024
Dianthus Therapeutics USD -31629000 3.19M Jun/2025
Divis Laboratories Ltd 5.45B 1.17B Jun/2025
Ionis Pharmaceuticals USD 123.55M 270.49M Jun/2025
IQVIA Holdings USD 266M 17M Jun/2025
Lupin INR 12.19B 4.47B Jun/2025
Moderna USD -825000000 146M Jun/2025
Organon & Co USD 145M 58M Jun/2025
Revvity USD 53.95M 11.71M Jun/2025
Tectonic Therapeutic USD -19980000 7.61M Jun/2025
Tilray USD -85342000 46.18M Nov/2024
Viatris USD -4600000 3.04B Jun/2025
Xeris Pharmaceuticals USD -1930000 52.91M Jun/2025